We are glad to announce that the special issue “Personalized Medicine in Blood Disease of Children” of the Journal of Personalized Medicine has been published.

This special issue includes a collection of seven articles focusing specifically on hemoglobinopathies, spanning countries around the world such as Australia, Cyprus, Germany, Indonesia, Italy, Kuwait, Malaysia, the Philippines, South Africa and the United Kingdom. The aim of the contributions is to highlight the current state of research and practice on personalized medicines in non-malignant blood diseases in children, a field of research that has seen significant progress in the last decade, including the emergence of gene therapy and other innovative therapies.

As summarized in the editorial (Prof. Adriana Ceci, Dr. Petros Kountouris, Dr. Antonella Didio, Dr. Fedele Bonifazi), a large space of the special issue is dedicated to SCD, the most frequent monogenic hereditary disease that affects millions of people all over the world. All contributions underline the relevance of genetic research to improve both diagnostic capacity and clinical management, as well as the importance of the prevention approach, through prenatal or postnatal screening. This is a topic that is still problematic because it is in conflict with ethical, religious, political and social issues in some countries.

The special issue is available for free here.

Subscribe To Our Newsletter

to keep you up to date on our activities and initiatives

La tua iscrizione non può essere convalidata.
La tua iscrizione è avvenuta correttamente.

We use Brevo as our marketing platform. By clicking below to submit this form, you are aware and accept that the information you have provided will be transferred to Brevo for treatment in accordance with their terms of use
Utilizziamo Brevo come nostra piattaforma di marketing. Cliccando qui sotto per inviare questo modulo, sei consapevole e accetti che le informazioni che hai fornito verranno trasferite a Brevo per il trattamento conformemente alle loro condizioni d'uso

You have Successfully Subscribed!

Pin It on Pinterest

Share This